- Home
- / Starpharma
Starpharma
Stock Price
$0.1
2024-10-18
Market Capitalization
$38.4 M
2024-10-18
Revenue
$4.9 M
FY, 2025
Starpharma Summary
Company Summary
- Overview
- Starpharma is a company specializing in the development of dendrimer products for the pharmaceutical and life science industries. It develops and commercializes dendrimer nanotechnology across diverse applications, including sexual health (VivaGel) and drug delivery for pharmaceuticals.
- Type
- Public
- Status
- Active
- Founded
- 1996
- HQ
- Abbotsford, AU | view all locations
- Website
- https://starpharma.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Zita Peach, Independent Non-Executive Director (Appointed 1 October 2011)
Tony Eglezos, Vice President, Business Development
Lynda Cheng, Independent Non-Executive Director (Appointed 1 August 2021)
LocationsView all
1 location detected
Abbotsford, VIC HQ
Australia
4-6 Southampton Cres
Starpharma Financials
Summary Financials
- Revenue (H1, 2026)
- $10.8M
- Gross profit (H1, 2026)
- $10.4M
- Net income (H1, 2026)
- $1.4M
- Cash (H1, 2026)
- $18.2M
- EBIT (H1, 2026)
- $1.0M